Pharmacokinetics of 2',3'-dideoxyinosine in monkeys
- PMID: 1929275
- PMCID: PMC284324
- DOI: 10.1128/AAC.35.6.1247
Pharmacokinetics of 2',3'-dideoxyinosine in monkeys
Abstract
Comparison of the pharmacokinetic parameters obtained for dideoxyinosine (ddI) in monkeys with those obtained for humans indicates that the monkey is an appropriate animal model for ddI pharmacokinetics in humans. Following intravenous administration of 20 mg of ddI per kg of body weight and measurement of ddI in plasma and urine by high-performance liquid chromatography, pharmacokinetic parameters were determined by noncompartmental analysis. Total systemic clearance was 0.74 liters/h/kg, volume of distribution was 0.92 liters/kg, and the elimination half-life of ddI was 1.22 h. The pharmacokinetics of ddI in five monkeys were determined following intravenous administration of 20 mg/kg and were found to be comparable to those obtained in patients with AIDS.
Similar articles
-
Pharmacokinetic evaluation of drug interactions with anti-HIV drugs, II: Effect of 2',3'-dideoxyinosine (ddI) on zidovudine kinetics in monkeys.AIDS Res Hum Retroviruses. 1992 Feb;8(2):277-83. doi: 10.1089/aid.1992.8.277. AIDS Res Hum Retroviruses. 1992. PMID: 1540413
-
Pharmacokinetics of zidovudine and dideoxyinosine alone and in combination in patients with the acquired immunodeficiency syndrome.Br J Clin Pharmacol. 1994 May;37(5):421-6. doi: 10.1111/j.1365-2125.1994.tb05708.x. Br J Clin Pharmacol. 1994. PMID: 8054247 Free PMC article. Clinical Trial.
-
Pharmacokinetics of 2',3'-dideoxyinosine (BMY-40900), a new anti-human immunodeficiency virus agent, after administration of single intravenous doses to beagle dogs.Antimicrob Agents Chemother. 1991 Apr;35(4):610-4. doi: 10.1128/AAC.35.4.610. Antimicrob Agents Chemother. 1991. PMID: 1906259 Free PMC article.
-
Pharmacokinetics of dideoxyinosine in pigtailed macaques (Macaca nemestrina) after intravenous and subcutaneous administration.J Acquir Immune Defic Syndr (1988). 1992 Oct;5(10):1016-8. J Acquir Immune Defic Syndr (1988). 1992. PMID: 1453316
-
Didanosine.Ann Pharmacother. 1992 May;26(5):660-70. doi: 10.1177/106002809202600511. Ann Pharmacother. 1992. PMID: 1350471 Review.
Cited by
-
Pharmacokinetics and metabolism of racemic 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rhesus monkeys.Antimicrob Agents Chemother. 1992 Nov;36(11):2432-8. doi: 10.1128/AAC.36.11.2432. Antimicrob Agents Chemother. 1992. PMID: 1336946 Free PMC article.
-
Antiviral activity and pharmacokinetics of 1-(2,3-dideoxy-2-fluoro-beta-L-glyceropent-2-enofuranosyl)cytosine.Antimicrob Agents Chemother. 2003 Jun;47(6):1922-8. doi: 10.1128/AAC.47.6.1922-1928.2003. Antimicrob Agents Chemother. 2003. PMID: 12760868 Free PMC article.
-
Pharmacokinetics of the anti-human immunodeficiency virus nucleoside analog stavudine in cynomolgus monkeys.Antimicrob Agents Chemother. 1993 May;37(5):1160-2. doi: 10.1128/AAC.37.5.1160. Antimicrob Agents Chemother. 1993. PMID: 8390811 Free PMC article.
-
Pharmacokinetics of the antiviral agent beta-L-3'-fluoro-2',3'-didehydro-2',3'-dideoxycytidine in rhesus monkeys.Antimicrob Agents Chemother. 2005 Feb;49(2):560-4. doi: 10.1128/AAC.49.2.560-564.2005. Antimicrob Agents Chemother. 2005. PMID: 15673733 Free PMC article.
-
Physiologically based pharmacokinetic models of 2',3'-dideoxyinosine.Pharm Res. 1997 Mar;14(3):337-44. doi: 10.1023/a:1012002206007. Pharm Res. 1997. PMID: 9098877
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources